Navigation Links
Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative
Date:6/24/2009

SEATTLE, June 24 /PRNewswire-USNewswire/ -- A Commonwealth Fund case study notes that Group Health Cooperative is structured with incentives aligned "to launch innovations and organize services in ways that make the most sense operationally and clinically."

The case study -- along other profiles looking at medical systems that have the attributes the Commonwealth Fund has identified as necessary for a high performing health care system -- has been in the works for more than a year. Commonwealth Fund President Karen Davis notes recent interest on Capitol Hill in cooperative structures, pointing to Group Health as a "shining example" of the model, while also praising other integrated systems.

"As the nation looks at how to create better health care, medical systems like Group Health that have pioneered a different approach, can provide some of the answers," said Group Health President and CEO Scott Armstrong. "Most important is setting up incentives that pay for quality care and keeping patients healthy rather than paying for the most care."

Here are the six attributes The Commonwealth Fund has identified, as experienced at Group Health:

Information Continuity

  • Electronic health record (EHR) system across all group-practice sites with integrated best-practice alerts, decision supports, and electronic prescribing.
  • Patient Web portal for online access to health information from the EHR, appointment scheduling, prescription refills, laboratory test results, and secure e-mail with clinicians.
  • Electronic health
    '/>"/>

SOURCE Group Health Cooperative
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... TechTeam Global, Inc ., (Nasdaq: ... technology outsourcing and business process outsourcing services, announced ... director of global life sciences services. Roumans will ... ongoing capability enhancement in support of TechTeam,s life ... of experience in the life sciences industry, most ...
(Date:2/9/2010)... Feb. 9 Delcath ... medical technology company testing its proprietary treatment system ... announced today the signing of its first research, ... Hepatic Perfusion (PHP) System  (the Delcath PHP System™). ... exclusive right to market and sell the Delcath ...
(Date:2/9/2010)... Feb. 9 Visage Imaging®, Inc., ... PME), announces today John Danahy joins as ... With over 17 years in the healthcare IT industry, ... team. ,, Danahy was previously VP Sales of ... developed new business opportunities in the EMR market segment. ...
Breaking Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3Delcath Signs First Partner Agreement in Asia 2Delcath Signs First Partner Agreement in Asia 3Delcath Signs First Partner Agreement in Asia 4Delcath Signs First Partner Agreement in Asia 5Visage Imaging Names John Danahy as General Manager North America, Sales and Services 2BIO key 28R 29 Selected as 2009 Industry Innovator in Biometrics by SC Magazine 11162 1BIO key 28R 29 Selected as 2009 Industry Innovator in Biometrics by SC Magazine 11162 2BIO key 28R 29 Selected as 2009 Industry Innovator in Biometrics by SC Magazine 11162 3Kampyle Experiences Record Growth in 2009 with 25 000 New Customers 63391 1Kampyle Experiences Record Growth in 2009 with 25 000 New Customers 63391 2Kampyle Experiences Record Growth in 2009 with 25 000 New Customers 63391 3Kampyle Experiences Record Growth in 2009 with 25 000 New Customers 63391 4Kampyle Experiences Record Growth in 2009 with 25 000 New Customers 63391 5Dermatologists Reach Skin Cancer Screening Milestone 63389 1Dermatologists Reach Skin Cancer Screening Milestone 63389 2Dermatologists Reach Skin Cancer Screening Milestone 63389 3
... - Results Show Good Distribution of Bevasiranib to Retina ... after a ... Health, Inc. (Amex: OPK ),today announced that a study ... siRNA (small,interfering RNA) agent is distributed throughout the eye, including,extensive ...
... Inc.,(Nasdaq: DCTH ) announced today that the St. ... Hospital & Health Network (St. Luke,s),has joined Delcath,s Phase ... in the liver using the Company,s,Percutaneous Hepatic Perfusion (PHP) ... agent melphalan. This Phase III multi-center,study is led by ...
Other Medicine Technology:Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 2Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 3Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 3
(Date:2/9/2010)... The Providence Service Corporation, one of ... nationwide, today announced that it plans to relocate its ... Providence , working with Peach Properties, will take over ... Broadway, adjacent to the new site of Tucson Electric ... Tucson ,s public companies side by side and ...
(Date:2/9/2010)... redesigned MxSecure, Inc. site: www.mxsecure.com . , ... ... -- Medical transcription services and EHR provider , MxSecure, ... , , , ,Improving Medical Practice Productivity from Day One. ... the focus of all the company,s products and services, from ...
(Date:2/9/2010)... insurance industry’s need for data-driven automation across all marketing, ... , ... Atlanta, GA ... service and process automation solutions to the health insurance ... with MedicareCRM. Through this partnership, Connecture and MedicareCRM ...
(Date:2/9/2010)... Doctors should consider preventive measures, study suggests , , TUESDAY, ... bowel disease are much more likely to develop blood ... suggests. , And that may make preventive drug treatment ... United Kingdom, compared data on 13,756 people who had ... not have it. None of the people were ...
(Date:2/9/2010)... wife owners of specialty cake bakery put on their "game faces" ... ... February 9, 2010 -- As the Saints and the Colts prepared ... and wife owners, Steven and Sophie Rojas Tallon, of Yummy ... in the NFL Super Bowl Tailgate Cake Contest on Sunday. Sophie ...
Breaking Medicine News(10 mins):Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 2Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 3Health News:Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity 2Health News:Connecture, Inc. Announces Partnership with MedicareCRM 2Health News:Connecture, Inc. Announces Partnership with MedicareCRM 3Health News:Inflammatory Bowel Ups Risk for Blood Clots 2Health News:Yummy Cakes and More Places 2nd in NFL Super Bowl Tailgate Cake Contest 2
... a new compound AN2690, that might help to attack ... crucial for the protein synthesis of fungal pathogens. ... researchers including Dickon Alley and Stephen Cusack at Anacor ... (EMBL) outstation in Grenoble, France. ,AN2690 interferes with ...
... Anglo-American company has been allowed to store white blood ... the US Food and Drug Administration. ,White ... system that defend the body against both infectious disease ... 480-millilitre of blood from interested healthy individuals and will ...
... welcomed the European Union (EU) Parliament's resolution to ban mercury ... to do likewise. ,Toxics Link and other ... ,The group had called upon governments across the world to ... Programme (UNEP) in February. ,In one of ...
... and other northern mid- and upper-latitude regions are playing ... thought , according to a study appearing in this ... light on the so-called missing carbon sink, concludes that ... of carbon dioxide from the atmosphere, thereby partially offsetting ...
... lady love Jenny McCarthy has revealed her plans about getting a ... couple will be spending as much time as possible on the ... sit and do nothing. Stare at the ocean and go 'ohhmmm, ... spending a lot of time with her beau on the beach, ...
... World Food Programme (WFP) has warned that continuing security problems ... in the west of the country where food stocks are ... soon see critical food supplies curtailed or interrupted. ... region of Afghanistan for four weeks due to insecurity. Unless ...
Other Medicine News:Health News:Researchers Devise New Compound to Treat Fungal Infections 2Health News:Northern Forests Less Effective Than Tropical Forests in Reducing Global Warming 2Health News:Northern Forests Less Effective Than Tropical Forests in Reducing Global Warming 3Health News:Insecurity Jepardising WFP Initiatives in Western Afghanistan 2
...
...
...
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium....
Medicine Products: